Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 17 open reading frame 67 (C17orf67) is a human protein encoded by the C17orf67 gene, classified as a protein-coding gene of unknown function[1][3][7]. The protein is predicted to localize to the extracellular region, but detailed experimental evidence for its function or localization is lacking[2][7]. Genome-wide association and genetic studies have linked variants in or near C17orf67 with increased pubertal height velocity and a predisposition to adolescent idiopathic scoliosis, as well as to developmental anomalies seen in 17q22 microdeletion syndrome, including intellectual disability and skeletal abnormalities[2]. However, the precise cellular role, molecular mechanism, and biochemical activities of C17orf67 remain undetermined. No drugs, therapeutic agents, or direct disease mechanisms are currently established, and the protein is regarded as uncharacterized in the biomedical literature[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 17 open reading frame 67 (C17orf67).